GO:0044818 mitotic G2/M transition checkpoint: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0044818 (mitotic G2/M transition checkpoint) is a biological process that detects and negatively regulates progression from G2 to M phase during mitosis.
• The checkpoint prevents cells with DNA damage or incomplete replication from entering mitosis, allowing repair or triggering apoptosis.
• Core regulators include CDK1, WEE1, MDC1, TRAP1, and MAD2, which control CDK1 activity and spindle assembly.
• Dysregulation of this checkpoint is implicated in cancer chemoresistance, melanoma, and non-small cell lung cancer.
• Targeting the G2/M checkpoint (e.g., WEE1 inhibition) is a promising synthetic lethal strategy in TP53-mutant tumors.
• CRISPR knockout, point mutation, and knock-in models are essential to dissect checkpoint gene function and validate therapeutic targets.
Description
The mitotic G2/M transition checkpoint (GO:0044818) is a cell cycle surveillance mechanism that ensures genomic integrity before cells commit to mitosis. It detects DNA damage, incomplete replication, or spindle defects and negatively regulates the G2-to-M phase transition, providing time for repair or inducing apoptosis if damage is irreparable. This checkpoint is critical for preventing the propagation of mutations and is a key barrier against oncogenesis. Researchers study this process to understand cancer resistance, develop targeted therapies, and model cell cycle disorders. The checkpoint integrates signals from sensor kinases (e.g., ATM/ATR), transducers (e.g., MDC1), and effectors (e.g., WEE1, CDK1) to halt the cell cycle. Its dysfunction is linked to chemoresistance and tumor progression, making it a prime target for synthetic lethal approaches.
mitotic G2/M transition checkpoint At A Glance
| GO ID | GO:0044818 |
|---|---|
| GO term | mitotic G2/M transition checkpoint |
| Ontology | biological_process |
| Synonym | None |
| Major function | Detects and negatively regulates progression from G2 to M phase in mitosis |
| Key regulators | CDK1, WEE1, MDC1, TRAP1, MAD2 |
| Associated diseases | Cancer (NSCLC, melanoma), chemoresistance |
| Research methods | CRISPR KO/point mutation/knock-in, RNA-seq, proteomics, imaging |
What Is GO:0044818?
The mitotic G2/M transition checkpoint is a biological process that monitors the completion of DNA replication and the presence of DNA damage during the G2 phase of the mitotic cell cycle. When abnormalities are detected, it negatively regulates progression into M phase, preventing cells from entering mitosis until conditions are favorable or until apoptosis is triggered.
Why Is mitotic G2/M transition checkpoint Important in Cell Biology?
The mitotic G2/M transition checkpoint is essential for maintaining genomic stability by preventing cells with damaged DNA from entering mitosis. Its dysregulation contributes to cancer development and resistance to chemotherapy, as tumor cells often rely on this checkpoint to survive genotoxic stress. Understanding its molecular players offers opportunities for targeted therapies, particularly in TP53-mutant cancers where the G2/M checkpoint is a critical survival pathway.
• Prevents genomic instability by halting mitosis until DNA damage is repaired.
• Plays a key role in chemoresistance, especially in TP53-mutant tumors.
• WEE1 inhibition abrogates the checkpoint and sensitizes cancer cells to alkylating agents.
• TRAP1 regulates CDK1 and MAD2, linking mitochondrial function to G2/M control.
• MDC1 is essential for G2/M transition and spindle assembly in oocytes.
• Golgi fragmentation serves as an organelle-based checkpoint during G2/M.
• Checkpoint abrogation is a synthetic lethal strategy in melanoma.
• Viral egress can exploit G2/M checkpoint regulation and apoptosis.
• Targeting the checkpoint enhances antitumor effects of KRAS-mutated NSCLC therapy.
• Provides a model for studying cell cycle checkpoints and organelle dynamics.
What Happens During mitotic G2/M transition checkpoint?
DNA Damage Sensing and Signal Transduction
In simple terms: The cell checks for DNA damage before dividing.
During G2 phase, sensor kinases such as ATM and ATR detect DNA double-strand breaks and replication stress. These kinases activate downstream transducers including MDC1, which is essential for G2/M transition and spindle assembly in mouse oocytes. MDC1 amplifies the damage signal and recruits effectors that inhibit CDK1 activity, preventing entry into mitosis. This sensing mechanism ensures that cells with damaged DNA do not proceed to M phase.
Inhibition of CDK1-Cyclin B Complex
In simple terms: The engine that drives mitosis is kept off.
The CDK1-cyclin B complex is the master regulator of mitotic entry. The G2/M checkpoint negatively regulates this complex through inhibitory phosphorylation of CDK1 at Tyr15 by WEE1 kinase. TRAP1 controls CDK1 and MAD2 expression and ubiquitination, thereby influencing G2-M transition. WEE1 inhibition leads to premature CDK1 activation and mitotic entry, abrogating the checkpoint.
Spindle Assembly Checkpoint and MAD2
In simple terms: The cell ensures chromosomes are ready to separate.
MAD2 is a key component of the spindle assembly checkpoint that prevents anaphase until all chromosomes are properly attached to the spindle. TRAP1 regulates MAD2 expression and ubiquitination, linking mitochondrial chaperone activity to spindle checkpoint control. MDC1 is also required for spindle assembly in oocytes, indicating a broader role in G2/M transition.
Organelle-Based Checkpoints: Golgi Fragmentation
In simple terms: Even cell organelles help control the division decision.
The Golgi complex undergoes fragmentation during G2/M transition, which serves as an organelle-based cell-cycle checkpoint. This fragmentation is required for proper mitotic progression and is coordinated with CDK1 activation. Disruption of Golgi fragmentation can delay or arrest the cell cycle, highlighting the integration of organelle dynamics with checkpoint control.
Apoptosis Induction and Viral Egress
In simple terms: If damage is too severe, the cell self-destructs.
When DNA damage is irreparable, the G2/M checkpoint can trigger apoptosis. In parvoviral infection, G2/M checkpoint regulation and apoptosis facilitate nuclear egress of viral capsids. This demonstrates how the checkpoint intersects with cell death pathways and can be exploited by pathogens.
Key Genes Involved in GO:0044818 mitotic G2/M transition checkpoint
The following genes and proteins are central to the regulation and function of the mitotic G2/M transition checkpoint.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CDK1 | Master kinase driving mitotic entry; inhibited by WEE1 | Target for checkpoint abrogation; essential for cell cycle progression |
| WEE1 | Phosphorylates CDK1 at Tyr15 to inhibit G2/M transition | Therapeutic target in TP53-mutant cancers; enhances antitumor effects |
| MDC1 | Mediator of DNA damage response; required for G2/M transition and spindle assembly | Essential for oocyte meiosis and genomic stability |
| TRAP1 | Mitochondrial chaperone; regulates CDK1 and MAD2 expression/ubiquitination | Links mitochondrial function to G2/M checkpoint control |
| MAD2 | Spindle assembly checkpoint protein; prevents anaphase until chromosomes align | Regulated by TRAP1; key for faithful chromosome segregation |
| ATM | DNA damage sensor kinase; activates checkpoint signaling | Upstream regulator of G2/M arrest |
| ATR | Replication stress sensor; activates checkpoint effectors | Coordinates G2/M arrest with DNA repair |
| CDC25C | Phosphatase that activates CDK1 by removing inhibitory phosphate | Counteracts WEE1; target for checkpoint control |
| PLK1 | Polo-like kinase; promotes mitotic entry and CDK1 activation | Interacts with checkpoint pathways |
| CCNB1 | Cyclin B1; regulatory subunit of CDK1 | Essential for mitotic entry; regulated by checkpoint |
| TP53 | Tumor suppressor; induces p21 and G2/M arrest after DNA damage | Loss of TP53 sensitizes cells to WEE1 inhibition |
| GOLGA2 | Golgi matrix protein; involved in Golgi fragmentation during G2/M | Organelle-based checkpoint component |
| GRASP65 | Golgi stacking protein; regulated during mitosis | Golgi fragmentation checkpoint |
| BUB1 | Spindle assembly checkpoint kinase | Monitors chromosome attachment |
| BUBR1 | Spindle assembly checkpoint protein | Prevents premature anaphase |
| MPS1 | Spindle assembly checkpoint kinase | Required for checkpoint activation |
| AURKA | Aurora kinase A; regulates mitotic entry and spindle assembly | Interacts with G2/M checkpoint |
| AURKB | Aurora kinase B; chromosome segregation and cytokinesis | Checkpoint regulation |
How Is mitotic G2/M transition checkpoint Regulated?
The mitotic G2/M transition checkpoint is regulated by a balance between inhibitory kinases (WEE1, MYT1) and activating phosphatases (CDC25C). WEE1 phosphorylates CDK1 at Tyr15, keeping it inactive, while CDC25C removes this phosphate to activate CDK1. TRAP1 controls CDK1 and MAD2 expression and ubiquitination, adding another layer of regulation. MDC1 is essential for G2/M transition and spindle assembly, linking DNA damage signaling to checkpoint control. Additionally, Golgi fragmentation serves as an organelle-based checkpoint that coordinates with CDK1 activation. The checkpoint is also influenced by viral infection, where G2/M regulation and apoptosis facilitate nuclear egress.
mitotic G2/M transition checkpoint and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| WEE1 | Non-small cell lung cancer with TP53 mutations | CRISPR knockout or point mutation in NSCLC cell lines |
| TP53 | Chemoresistance in glioblastoma | Knock-in of TP53 mutations in neuro-oncology models |
| MDC1 | Oocyte meiotic defects and infertility | Knockout mouse oocytes or overexpression in cell lines |
| TRAP1 | Mitochondrial dysfunction and cancer | Point mutation or knockout in cancer cell lines |
| MAD2 | Spindle assembly checkpoint defects and aneuploidy | Knockout or knockdown in melanoma models |
Cancer Chemoresistance and Synthetic Lethality
The G2/M checkpoint is often upregulated in cancer cells to survive DNA-damaging chemotherapy. Targeting WEE1 enhances the antitumor effect of KRAS-mutated non-small cell lung cancer harboring TP53 mutations. Abrogation of the G2/M checkpoint as a chemosensitization approach for alkylating agents has been demonstrated in neuro-oncology. Synthetic lethality targeting cell cycle regulation via the G2-M checkpoint is a promising strategy in melanoma.
Oocyte Meiosis and Reproductive Disorders
MDC1 is essential for G2/M transition and spindle assembly in mouse oocytes, and its loss leads to meiotic defects. This highlights the importance of the checkpoint in reproductive biology and potential links to infertility.
Viral Pathogenesis
Parvoviral capsids exploit G2/M checkpoint regulation and apoptosis to facilitate nuclear egress, indicating that viruses can manipulate this checkpoint for their life cycle.
Mitochondrial Dysfunction and Metabolic Stress
TRAP1, a mitochondrial chaperone, controls cell cycle G2-M transition through regulation of CDK1 and MAD2, linking mitochondrial metabolism to checkpoint control. Dysregulation may contribute to metabolic diseases and cancer.
From mitotic G2/M transition checkpoint-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does WEE1 inhibition sensitize TP53-mutant NSCLC to chemotherapy? | CRISPR knockout of WEE1 in TP53-mutant NSCLC cell lines |
| What is the role of MDC1 in oocyte G2/M transition? | Knockout mouse oocytes or CRISPR knockout in oocyte cell lines |
| How does TRAP1 regulate CDK1 and MAD2? | Point mutation or knockout of TRAP1 in cancer cells |
| Can G2/M checkpoint abrogation overcome alkylating agent resistance? | CRISPR knockout of checkpoint genes in glioblastoma models |
| Is MAD2 required for spindle assembly checkpoint in melanoma? | Knockout or knockdown of MAD2 in melanoma cell lines |
| Does Golgi fragmentation serve as a checkpoint? | Knock-in of tagged Golgi proteins or knockout of GOLGA2 |
How to Study the mitotic G2/M transition checkpoint Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screening | Gene essentiality and synthetic lethality | Identify checkpoint regulators in cancer cells |
| RNA-seq | Transcriptional changes | Measure CDK1, MAD2, and other gene expression |
| Proteomics | Protein abundance and modifications | Quantify CDK1 phosphorylation and MAD2 ubiquitination |
| Live-cell imaging | Dynamic protein localization and cell cycle progression | Visualize Golgi fragmentation and spindle assembly |
| Flow cytometry | Cell cycle phase distribution | Assess G2/M arrest after DNA damage |
| Western blot | Protein expression and phosphorylation | Detect CDK1 Tyr15 phosphorylation by WEE1 |
| Immunofluorescence | Subcellular localization | Visualize MDC1 and spindle assembly |
| Apoptosis assays | Cell death induction | Measure apoptosis after checkpoint abrogation |
CRISPR-Cas9 Knockout Screening
Genome-wide CRISPR knockout screens can identify genes essential for G2/M checkpoint function. For example, targeting WEE1 enhances antitumor effects in KRAS-mutated NSCLC. Libraries targeting cell cycle genes can reveal synthetic lethal interactions.
RNA Sequencing and Transcriptomics
RNA-seq measures gene expression changes upon checkpoint activation or inhibition. It can reveal upregulation of CDK1, MAD2, and other effectors.
Proteomics and Ubiquitination Assays
Proteomics can quantify CDK1 and MAD2 protein levels and ubiquitination status, as shown for TRAP1 regulation. This helps dissect post-translational control.
Imaging and Live-Cell Microscopy
Fluorescence microscopy can visualize Golgi fragmentation, spindle assembly, and chromosome segregation during G2/M transition. Live-cell imaging with fluorescently tagged CDK1 or MAD2 provides dynamic insights.
How CRISPR Can Be Used to Study GO:0044818 mitotic G2/M transition checkpoint
Knockout
CRISPR knockout of WEE1, MDC1, or TRAP1 can abrogate the G2/M checkpoint, leading to premature mitotic entry and cell death. Knockout models are used to validate gene function and synthetic lethal interactions.
Point Mutation
Point mutations in CDK1 (e.g., T14A/Y15F) prevent inhibitory phosphorylation, mimicking checkpoint abrogation. Such models help dissect phosphorylation-dependent regulation.
Knock-in
Knock-in of tagged CDK1 or MAD2 allows live-cell imaging of checkpoint dynamics. Knock-in of disease-associated mutations (e.g., TP53) can model chemoresistance.
Overexpression
Overexpression of WEE1 or TRAP1 can enhance checkpoint stringency and chemoresistance. Overexpression models are useful for studying gain-of-function mechanisms.
How EDITGENE Supports mitotic G2/M transition checkpoint Research
Researchers studying mitotic G2/M transition checkpoint-related genes often need to determine whether a candidate gene is causally involved in checkpoint control, DNA damage response, or chemoresistance. EDITGENE provides comprehensive CRISPR services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for mitotic G2/M transition checkpoint research.
Frequently Asked Questions About mitotic G2/M transition checkpoint
What is the mitotic G2/M transition checkpoint?
It is a cell cycle checkpoint that detects DNA damage or incomplete replication and negatively regulates progression from G2 to M phase, preventing cells from entering mitosis until conditions are favorable.
What genes are involved in the mitotic G2/M transition checkpoint?
Key genes include CDK1, WEE1, MDC1, TRAP1, MAD2, ATM, ATR, and CDC25C.
How does the G2/M checkpoint prevent cancer?
By halting the cell cycle to allow DNA repair or inducing apoptosis, it prevents the propagation of mutations that could lead to cancer.
What is the role of WEE1 in the G2/M checkpoint?
WEE1 phosphorylates CDK1 at Tyr15, inhibiting its activity and preventing mitotic entry until DNA damage is repaired.
How is the G2/M checkpoint targeted in cancer therapy?
Inhibitors of WEE1 or other checkpoint kinases abrogate the checkpoint, forcing cancer cells with DNA damage into premature mitosis and causing cell death.
What is the relationship between TP53 and the G2/M checkpoint?
TP53 induces G2/M arrest after DNA damage; loss of TP53 makes cells more reliant on the G2/M checkpoint, creating a therapeutic vulnerability.
What methods are used to study the G2/M checkpoint?
CRISPR knockout screens, RNA-seq, proteomics, live-cell imaging, and flow cytometry are commonly used.
What is the role of MDC1 in G2/M transition?
MDC1 is essential for G2/M transition and spindle assembly in mouse oocytes, linking DNA damage signaling to checkpoint control.
How does TRAP1 regulate the G2/M checkpoint?
TRAP1 controls CDK1 and MAD2 expression and ubiquitination, thereby influencing G2-M transition.
Can CRISPR be used to model G2/M checkpoint disorders?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect checkpoint gene function and validate therapeutic targets.
Conclusion
The mitotic G2/M transition checkpoint (GO:0044818) is a critical safeguard for genomic integrity, coordinating DNA damage detection with cell cycle arrest and apoptosis. Its dysregulation is central to cancer chemoresistance and other diseases, making it a prime target for therapeutic intervention. CRISPR-based models are indispensable for dissecting the molecular players and developing targeted strategies. EDITGENE offers comprehensive services to accelerate research on this essential checkpoint.
References
- 1. Fukuda K et al.. 2024. Targeting WEE1 enhances the antitumor effect of KRAS-mutated non-small cell lung cancer harboring TP53 mutations.. Cell Rep Med 5(6):101578 PMID: 38776912
- 3. Mattola S et al.. 2022. G2/M checkpoint regulation and apoptosis facilitate the nuclear egress of parvoviral capsids.. Front Cell Dev Biol 10:1070599 PMID: 36568985
- 4. Sisinni L et al.. 2017. TRAP1 controls cell cycle G2-M transition through the regulation of CDK1 and MAD2 expression/ubiquitination.. J Pathol 243(1):123-134 PMID: 28678347
- 5. Leem J et al.. 2022. MDC1 is essential for G2/M transition and spindle assembly in mouse oocytes.. Cell Mol Life Sci 79(4):200 PMID: 35320416
- 6. Corda D et al.. 2012. Golgi complex fragmentation in G2/M transition: An organelle-based cell-cycle checkpoint.. IUBMB Life 64(8):661-70 PMID: 22730233
- 7. Lang F et al.. 2024. Abrogation of the G2/M checkpoint as a chemosensitization approach for alkylating agents.. Neuro Oncol 26(6):1083-1096 PMID: 38134889
- 8. Barnaba N et al.. 2021. Targeting cell cycle regulation via the G2-M checkpoint for synthetic lethality in melanoma.. Cell Cycle 20(11):1041-1051 PMID: 33966611
